Balboa Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Buy
4,342
+325
+8% +$26.2K 0.05% 314
2026
Q1
$348K Sell
4,017
-335
-8% -$32.1K 0.06% 271
2025
Q4
$418K Buy
4,352
+1,986
+84% +$193K 0.07% 225
2025
Q3
$225K Sell
2,366
-17
-0.7% -$1.56K 0.04% 333
2025
Q2
$208K Sell
2,383
-39
-2% -$3.31K 0.04% 317
2025
Q1
$218K Sell
2,422
-145
-6% -$13K 0.05% 253
2024
Q4
$205K Sell
2,567
-88
-3% -$7.62K 0.05% 275
2024
Q3
$239K Buy
+2,655
New +$223K 0.06% 233
2023
Q3
Sell
-2,399
Closed -$211K 309
2023
Q2
$211K Sell
2,399
-147
-6% -$12.7K 0.07% 221
2023
Q1
$205K Buy
+2,546
New +$208K 0.08% 227

Other funds holding MDT

Balboa Wealth Partners's MDT Position: Q2 2026 in Review

Balboa Wealth Partners increased its Medtronic (MDT) stake by 8.1% in Q2 2026, buying an estimated $26.2K and bringing the position to 4,342 shares worth $340K. The position accounts for 0.05% of the portfolio, ranked #314.

Balboa Wealth Partners first reported a position in MDT in Q1 2023 and has held it in 10 quarters since. The position peaked at $418K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Balboa Wealth Partners held 4,342 shares of Medtronic worth $340K as of Q2 2026.
  • Balboa Wealth Partners bought 325 Medtronic shares in Q2 2026, an estimated $26.2K.
  • Medtronic made up 0.05% of Balboa Wealth Partners's portfolio in Q2 2026, its #314 holding.
  • Balboa Wealth Partners first reported a position in Medtronic in Q1 2023 and has held it in 10 quarters since.
  • Balboa Wealth Partners's Medtronic position peaked at $418K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Balboa Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.